08:06 EDT Lexeo Therapeutics files to sell 6.97M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LXEO:
- Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing
- Lexeo Therapeutics price target raised to $24 from $22 at RBC Capital
- Lexeo Therapeutics’ Strategic $95M Share Placement and Financial Update
- Lexeo Therapeutics reports protein expression data from SUNRISE-FA trial
- Lexeo Therapeutics expects cash to fund operations into 2027